$6.86
Today
as of Sep 4, 16:49 ET
Last 30 days
Recent Press Releases & News
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
Overview
52-week range
$5.44
$9.42
36% of range
Avg surprise (last 3)
-55.6%
Avg reaction (last 2)
-5.8%
50% positive
Latest IV / EM
477%
EM ±82.2% · $8 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.12 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.08 | $-0.06 | -33.3% | — | -12.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.03 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $0.02 | $0.03 | -33.3% | — | — | earnings |
| Fri May 9, 2025 | Mar/2025 | — | $0.03 | -100.0% | — | +0.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.01 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.01 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.05 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.02 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.03 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | — | $31M | $30M | $22M | — | $25M |
| Cost of revenue | $2M | $1M | — | $2M | $1M | $894,000 | — | $958,000 |
| Gross profit | — | — | — | $29M | $26M | $21M | — | $25M |
| Operating income | $-14M | $-9M | — | $7M | $-2M | $2M | — | $4M |
| Net income | $-14M | $-19M | — | $6M | $-2M | $5M | — | $3M |
| EPS (diluted) | $-0.12 | $-0.10 | — | $0.03 | $-0.03 | — | — | $0.01 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $43M | $38M | $49M | $40M | $36M | $15M | $12M | $16M |
| Inventory | $11M | $11M | $10M | — | $9M | $8M | $6M | $6M |
| Total current assets | $122M | $92M | $149M | $99M | $91M | $68M | $65M | $55M |
| Total assets | $199M | $162M | $220M | $159M | $153M | $130M | $125M | $125M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $34M | $25M | $31M | $22M | $23M | $25M | $27M | $27M |
| Total equity | $108M | $43M | $62M | $102M | $60M | $41M | $63M | $98M |